The Lawyer Asia Pacific 150 is the only research report to provide a ranking of the top 100 independent local firms and top 50 global firms in the region. The report offers critical review of some of the fastest growing firms and their strategies, a country-by-country guide to leading legal advisers and legal services market trends, plus exclusive insight into the current business development opportunities in the Asia Pacific. Read more
This year, The Lawyer’s annual ranking of the largest UK law firms by turnover is available as an interactive, digital benchmarking tool. For the first time this will allow you to manipulate each data set against the metrics of your choice.
Berryman Lace Mawer (BLM) has secured new mandates for the NHS Litigation Authority (NHSLA), which today named a new lineup for its £400m clinical negligence and non-clinical negligence legal panels as well as its new regulatory, health and disciplinary panel.
A third panel has been introduced by the NHSLA this year to provide legal advice to 15 Department of Health organisations. A spokesperson said of the new panel: “[It will aim] to give access to top quality legal advice on health related issues at economic rates.”
The contracts will last for four years and is worth between £300m and £400m, according to the tender. The tender was initially due to take place in December. A supplier day was also delayed and took place on 22 February.
In the 2011/12 financial year the NHSLA received over 9,100 new clinical negligence claims and more than 4,600 non-clinical negligence claims. It spent over £1bn on clinical negligence claims and around £50m on non-clinical negligence matters.
In April last year the authority appointed NSPCC general counsel Catherine Dixon as its new chief executive, replacing Stephen Walker.